NFKB1 and hepatocellular carcinoma: Activation of the NF-κB and STAT3 inflammatory pathways was also evident (F6C), with activation of these two pathways in the non-tumour liver tissues of HCC patients previously reported to be associated with higher tumour recurrence26.